# PharmacofMRI of Anxiolytic Medications (Pregabalin)

> **NCT00706836** · PHASE4 · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 16 (actual)

## Conditions studied

- Anxiety Disorders

## Interventions

- **DRUG:** Pregabalin 50mg
- **DRUG:** Pregabalin 200 MG
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00706836
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706836, "PharmacofMRI of Anxiolytic Medications (Pregabalin)". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00706836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*